Hermann Josef Vormoor

After his medical degree, Professor Josef Vormoor trained as a paediatrician and paediatric oncologist in Münster. Germany (including a 3 year postdoctoral fellowship at the Hospital for Sick Children, Toronto). Since then he has worked as a paediatric haematologist in 3 health systems across Europe: 1999 – 2005 at the University Children’s Hospital Münster; 2006 – 2017 at the Great North Children’s Hospital, Newcastle, UK; and since 2018 at the Princess Máxima Centrum in Utrecht, the Netherlands. From 2013 to 2017, he was director of the Northern Institute for Cancer Research at Newcastle University and since June 2018 he is the founding clinical director of the Department of Hemato-oncology at the Princess Máxima Centrum. Professor Vormoor received his research MD from Münster University for his work on childhood AML. He gained further research experience as a postdoc in Professor John Dick’s lab at the Hospital for Sick Children in Toronto, working on normal and leukemic hematopoietic stem cells. His research has evolved from mechanism of leukemic stemness to communication of the leukemic cells with their microenvironment and the preclinical and early clinical drug development for childhood leukaemia. He has been overseeing the development of the paediatric allogeneic stem cell transplantion programme in Munster, the development of a CAR T cell programme at the Princess Máxima Center and is coordinating the development of AYA services at the interface of the Princess Máxima Center with the Utrecht University Medical Center. He chairs the EHA Pediatric SWG and is co-chair of the EHA taskforce on AYA.